Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Shah S, Diwan S, Soin A, Rajput K, Mahajan A, Manchikanti L, Kaye A, Hirsch J, Gharibo C. Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician 2020, 23: s161-s182. PMID: 32942784, DOI: 10.36076/ppj.2020/23/s161.Peer-Reviewed Original ResearchConceptsAmerican Society of Interventional Pain PhysiciansContinuity of careChronic pain patientsPain specialistsInterventional pain physiciansPain patientsInterventional pain specialistsPain carePain physiciansRisk of COVID-19 morbidityEvidence-informed guidanceCOVID-19 pandemicRisk factorsCOVID-related morbidityEvaluate risk-benefitCare recommendationsNumerous risk factorsManaging symptomsEvidence synthesisDisclosure of conflictsInterventional Pain PracticePain practiceTelemedicine encountersRisk stratification toolGuideline preparationValue and Validity of Coronavirus Antibody Testing.
Mahajan A, Manchikanti L. Value and Validity of Coronavirus Antibody Testing. Pain Physician 2020, 23: s381-s390. PMID: 32942795, DOI: 10.36076/ppj.2020/23/s381.Peer-Reviewed Original ResearchConceptsAntibody testIgM antibodiesImmune response to SARS-CoV-2 infectionTesting health care workersInterventional proceduresElective interventional proceduresPain management communityResponse to SARS-CoV-2 infectionElective surgical proceduresDays post-symptom onsetSARS-CoV-2 infectionPost-symptom onsetInfected patientsSurgical proceduresViral infectionPatientsIgG antibodiesImmunoglobulin MRe-infectionDetect IgGInfectionSARS-CoV-2Total antibodiesAntibodiesIgG/IgM test